TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease

Autoimmune (AI) diseases can affect many organs; however, the prostate has not been considered to be a primary target of these systemic inflammatory processes. Here, we utilize medical record data, patient samples, and in vivo models to evaluate the impact of inflammation, as seen in AI diseases, on...

Descripción completa

Detalles Bibliográficos
Autores principales: Vickman, Renee E., Aaron-Brooks, LaTayia, Zhang, Renyuan, Lanman, Nadia A., Lapin, Brittany, Gil, Victoria, Greenberg, Max, Sasaki, Takeshi, Cresswell, Gregory M., Broman, Meaghan M., Paez, J. Sebastian, Petkewicz, Jacqueline, Talaty, Pooja, Helfand, Brian T., Glaser, Alexander P., Wang, Chi-Hsiung, Franco, Omar E., Ratliff, Timothy L., Nastiuk, Kent L., Crawford, Susan E., Hayward, Simon W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018703/
https://www.ncbi.nlm.nih.gov/pubmed/35440548
http://dx.doi.org/10.1038/s41467-022-29719-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018703/
https://www.ncbi.nlm.nih.gov/pubmed/35440548
http://dx.doi.org/10.1038/s41467-022-29719-1

Ejemplares similares